Correlation Between Bank of America and Xeris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bank of America and Xeris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Xeris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Xeris Pharmaceuticals, you can compare the effects of market volatilities on Bank of America and Xeris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Xeris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Xeris Pharmaceuticals.
Diversification Opportunities for Bank of America and Xeris Pharmaceuticals
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Bank and Xeris is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Xeris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xeris Pharmaceuticals and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Xeris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xeris Pharmaceuticals has no effect on the direction of Bank of America i.e., Bank of America and Xeris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bank of America and Xeris Pharmaceuticals
Considering the 90-day investment horizon Bank of America is expected to generate 0.86 times more return on investment than Xeris Pharmaceuticals. However, Bank of America is 1.16 times less risky than Xeris Pharmaceuticals. It trades about 0.24 of its potential returns per unit of risk. Xeris Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest 4,262 in Bank of America on August 27, 2024 and sell it today you would earn a total of 438.00 from holding Bank of America or generate 10.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bank of America vs. Xeris Pharmaceuticals
Performance |
| Timeline |
| Bank of America |
| Xeris Pharmaceuticals |
Bank of America and Xeris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bank of America and Xeris Pharmaceuticals
The main advantage of trading using opposite Bank of America and Xeris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Xeris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xeris Pharmaceuticals will offset losses from the drop in Xeris Pharmaceuticals' long position.| Bank of America vs. Toronto Dominion Bank | Bank of America vs. Nu Holdings | Bank of America vs. HSBC Holdings PLC | Bank of America vs. Bank of Montreal |
| Xeris Pharmaceuticals vs. Capricor Therapeutics | Xeris Pharmaceuticals vs. Soleno Therapeutics | Xeris Pharmaceuticals vs. Bio Path Holdings | Xeris Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |